TEVA - Teva Pharmaceutical Industries Limited

NYSE - NYSE Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 524.3B
Enterprise Value 356.83B
Trailing P/E N/A
Forward P/E 18.40
PEG Ratio (5 yr expected) 1-1.56
Price/Sales (ttm)1.17
Price/Book (mrq)1.71
Enterprise Value/Revenue 32.73
Enterprise Value/EBITDA 610.33

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Jun 30, 2018


Profit Margin -48.10%
Operating Margin (ttm)16.65%

Management Effectiveness

Return on Assets (ttm)2.82%
Return on Equity (ttm)-41.46%

Income Statement

Revenue (ttm)20.78B
Revenue Per Share (ttm)20.43
Quarterly Revenue Growth (yoy)-17.80%
Gross Profit (ttm)10.89B
Net Income Avi to Common (ttm)-10.26B
Diluted EPS (ttm)-10.09
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.86B
Total Cash Per Share (mrq)1.83
Total Debt (mrq)30.24B
Total Debt/Equity (mrq)156.12
Current Ratio (mrq)1.03
Book Value Per Share (mrq)13.93

Cash Flow Statement

Operating Cash Flow (ttm)4.59B
Levered Free Cash Flow (ttm)2.88B

Trading Information

Stock Price History

Beta 1.07
52-Week Change 341.14%
S&P500 52-Week Change 317.34%
52 Week High 325.96
52 Week Low 310.85
50-Day Moving Average 323.12
200-Day Moving Average 321.33

Share Statistics

Avg Vol (3 month) 310.96M
Avg Vol (10 day) 316.25M
Shares Outstanding 51.02B
Float 930.27M
% Held by Insiders 14.05%
% Held by Institutions 166.74%
Shares Short (Aug 31, 2018) 438.79M
Short Ratio (Aug 31, 2018) 42.99
Short % of Float (Aug 31, 2018) 4N/A
Short % of Shares Outstanding (Aug 31, 2018) 43.81%
Shares Short (prior month Jul 31, 2018) 437.24M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.09
Trailing Annual Dividend Yield 30.35%
5 Year Average Dividend Yield 43.13
Payout Ratio 4N/A
Dividend Date 3Dec 12, 2017
Ex-Dividend Date 4Nov 27, 2017
Last Split Factor (new per old) 22/1
Last Split Date 3Jul 1, 2004